WO2002025277A1 - Heart-lung machine provided with a device for electrical impedance measurement, and method therefore - Google Patents

Heart-lung machine provided with a device for electrical impedance measurement, and method therefore

Info

Publication number
WO2002025277A1
WO2002025277A1 PCT/NL2001/000701 NL0100701W WO2002025277A1 WO 2002025277 A1 WO2002025277 A1 WO 2002025277A1 NL 0100701 W NL0100701 W NL 0100701W WO 2002025277 A1 WO2002025277 A1 WO 2002025277A1
Authority
WO
Grant status
Application
Patent type
Prior art keywords
blood
φ
rt
sd
characterized
Prior art date
Application number
PCT/NL2001/000701
Other languages
French (fr)
Inventor
Gheorghe Aurel Marie Pop
Original Assignee
Martil Instruments B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • A61M1/367Circuit parts not covered by the preceding subgroups of group A61M1/3621
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3607Regulation parameters
    • A61M1/3609Physical characteristics of the blood, e.g. haematocrit, urea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/65Impedance, e.g. conductivity, capacity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
    • G01N27/02Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means by investigating the impedance of the material

Abstract

The invention relates to a blood transporting machine, at least comprising transport means for transporting blood, wherein the blood transporting machine is further provided with a device for electrical impedance measurement of the blood, which comprises means for generating an electrical current in the blood, means for measuring the electrical impedance and means for recording the electrical impedance and/or impedance change in the blood. The blood transporting machine also comprises processing means for processing recorded impedance to a blood viscosity value.

Description

HEART-LUNG MACHINE PROVIDED WITH A DEVICE FOR ELECTRICAL IMPEDANCE MEASUREMENT ,

AND METHOD THEREFORE

The present invention relates to a blood transporting machine as according to the heading of claim 1.

A blood transporting machine is used for extracorpo- real circulation of blood. Examples hereof are a heart- lung machine and an artificial kidney machine.

An open-heart operation is usually performed with a heart-lung machine (HLM) . Cerebral dysfunction and to a lesser extent kidney function disorders are frequently occurring problems for patients as a result of this operation. These cerebral and renal problems not only cause a greater or lesser degree of permanent invalidity for the patient, but also result in hospital accommodation costs in the short term and costs of care in the longer term.

One of the causes of renal and cerebral disorders is formed by a rise in the viscosity of the blood, which is caused by hypothermia and by the "acute phase" reaction generated in the body by the operation. Increased viscosity is linked to reduced cerebral microcirculation. Hyperviscosity resulting from hypothermia affects the renal function. In addition, the moments of canulating, manipulation of the heart and declamping of the aorta are significant surgical sources of the occurrence of micro- embolisms. Despite the use of different filters in conjunction with the HLM, a significant part of the micro- embolisms is still found to occur as a result of perfusi- on problems associated with the HLM.

The present invention has for its object to monitor the viscosity of blood when it is transported extracorpo- really by a blood transporting machine.

This objective is achieved with the present invention by providing a blood transporting machine of the above stated type, further comprising means for processing the impedance value to a viscosity value. The blood viscosity of a patient being treated can be measured with the blood transporting machine according to the invention.

It is favourable to embody the blood transporting machine as according to claim 2. It is hereby possible to monitor the blood viscosity value during open-heart operations. When the recorded blood viscosity value changes in adverse manner, external intervention can take place, for instance with medication.

Claim 3 is preferably applied. The electrical impe- dance measurement in the blood hereby takes place as soon as it is transported out of the blood transporting machine. A viscosity value for the blood is hereby obtained in a short time.

Claim 4 is preferably applied. Measuring of the impedance of the blood hereby becomes possible in efficient manner.

According to claim 5 the blood transporting machine is preferably embodied with a set of measuring electrodes . The impedance of the blood can hereby be measured between the measuring electrodes.

In the preferred embodiment the electrodes are circular. Such an embodiment allows the electrodes to enclose the perfusion tube.

The blood transporting machine is preferably embo- died with platinum electrodes. The use of platinum electrodes has a favourable effect on the accuracy of the value determination of the viscosity of the blood.

The electrodes are preferably arranged at a regular distance from each other in the longitudinal direction of the perfusion tube. A homogeneous electrical field in the blood is hereby achieved.

It is favourable to embody the heart-lung machine as according to claim 9. Such a ratio is effective for the homogeneity of the electrical field to be applied and measured.

The measure as according to claim 10 has a favourable effect on the accuracy of the measurement of the impedance value, and therefore on the accuracy of the blood viscosity to be determined.

In a preferred embodiment according to the invention the measure of claim 11 is applied in the blood transpor- ting machine. Particular medications administered to a patient when blood is circulated outside the body influence the sodium concentration in the blood of the patient. The sodium concentration influences the impedance of the blood. Inclusion of the sodium concentration in the algorithm for processing the impedance signal produces a more accurate determination of the viscosity value of the blood.

The invention also relates to and provides a.method for the operation of the heart-lung machine according to the invention. The method according to the invention relates in particular to detecting embolisms in the blood.

The method according to the invention preferably comprises of detecting air embolisms and/or micro-embo- lisms.

In a preferred embodiment according to the invention the blood transporting machine is embodied with temperature measuring means and means for measuring the haemato- crit value of the blood. These values can hereby also be monitored. The relation between the electrical impedance of the blood and the viscosity depends on the temperature and is also determined by the haematocrit value. For processing of the impedance signal to a viscosity value a calculation of the impedance signal is necessary with an algorithm dependent on the temperature and the haematocrit value.

It is favourable to determine correlation values for the relation between impedance of the blood and viscosity in relation to the temperature and the haematocrit value. The correlation coefficients are determined by doing an experiment with a large group of people. These are incorporated in the algorithm for processing the impedance signal to a viscosity value. An apparatus and a method for detecting the presence of embolisms in a tube through which blood or other fluid flows using a blood impedance measuring system is otherwise known from US 4,014,206. The invention is further elucidated with reference to the annexed figures, in which:

Figure 1 shows a schematic view of a preferred embodiment of the device for electrical impedance measurement of the blood in a heart-lung machine; Figure 2 shows a graph of a measurement signal for the impedance with the embodiment of figure 1 ;

Figure 3 shows a graph of an example of change in the impedance in accordance with a measurement with the embodiment of figure 1; Figure 4 shows a schematic view of a device for electrical impedance measurement of the blood, wherein particles flow in the blood;

Figure 5 shows a graph of the relation between impedance and viscosity corrected according to the inven- tion.

Figure 1 shows a schematic view of a preferred embodiment of the measuring device 1 for electrical impedance measurement of the blood in a blood transporting machine. The measuring device of the blood transpor- ting machine comprises two outer current electrodes 2,3 and two inner measuring electrodes 4,5 in the perfusion tube 6, immediately after the source from the blood transporting machine. Electrodes 2-5 are preferably circular and of platinum or stainless steel with a layer of precious metal. In order to obtain a homogeneous electrical field the distances between electrodes 2-5 are chosen so as to be more than twice the diameter of the perfusion tube 6 coming out of the blood transporting machine. By generating a low alternating current (10mA - 1mA) with a frequency between 4 kHz and 5000 kHz with an alternating current source 7 via the two outer electrodes 2,3, it will be possible via measuring electrodes 4,5 to continuously measure an impedance (ZO) of the blood passing the measuring electrodes. The impedance is acquired by measuring means 8.

Also shown is a sodium concentration measuring means 9 which is arranged in perfusion tube 6. Processing means 10 processes the measured value to a blood viscosity value which can be shown on a screen 11. The processing means can also be embodied to detect the occurrence of embolisms in the blood, air and/or micro-embolisms in particular. An example of an impedance signal as measured with the embodiment of figure 1 is shown in figure 2. A continuous recording of the change in the impedance signal (delta Z) can likewise take place. An example of a measurement signal of the change in the impedance signal is shown in figure 3.

It is known that blood has electrical properties. These electrical properties differ for plasma and blood cells. The plasma and the interior of the cells consist of conducting fluids with a determined electrical resis- tance and cell membranes consist of phospholipids and proteins with di-electrical properties. The electrical impedance of blood is determined primarily by three parameters: plasma resistance, internal resistance in the cell and the capacitance of the cell membrane. The elec- trical impedance of the blood increases with an increased viscosity of the blood. Just as the viscosity, the electrical impedance of blood increases during hypothermia and this is determined to a large degree by the haematocrit . Small particles (< 100 micron) with an impedance other than blood will become manifest in a sudden change in the impedance signal (Figures 2 + 3) . These changes can be seen particularly in the deltaZ signal and the magnitude of this change depends on the difference in specific resistance of the particles and of blood. During passage of air particles a large deflection will occur in the deltaZ signal in view of the clearly higher specific resistance of air relative to blood. This deflection of

H- tr rr tr ϋ 3 CO rt Ω <! H- g o φ rt z ?r rt Ω H- 3 SD o TJ rt μ- TJ rt CQ 0 m SD CQ TJ rt g Φ H Φ Φ H- 3" SD Φ 3 Φ K tr μ- 3 tr 3 Φ ϋ 3 ϋ tr φ • ϋ μ- d 3 3- g SD tr

TJ rt SD rt CQ i LQ Φ rt CQ 3 o Φ Φ O φ Φ rt Ω 1—1. CQ 0 K SD Φ O Ω Ω Φ SD ϋ Φ

Φ Z rt Z Φ H- 3 H- rt e rt Ω z CQ 0 Φ d tr o ? • <! CQ tr ^ Φ rt

U Φ H- Φ SD Ω H- 0 O Φ Φ CQ z rt *ϋ 3 Ω CQ CQ 0 h-1 g SD μ- Si CQ μ- Si w Φ O Φ ti S l-h rt 3 CO SD H- > ϋ SD SD 0 ≤ rt ≥; CQ rt Hi Φ r LQ Z Pi 0 SD μ- Φ CQ Ω φ

3 3 3 3 Ω rt H- * CQ rt P 0 rr 3 0 ii -> rt 3 H- tr 0 SD Φ 3 0 φ tr Φ Hi CQ 3 Hi φ Ω

Ω - K- Ω Φ CQ Ω 3^ 0 Pi rt CQ 1 rt rt Φ rt H P. CQ rt Φ i ϋ Φ rt

Φ rt 0 rt 0 SD M o 0 Ω rt Φ H- 0 Φ H- tr ^ 3 Z H- μ- rt μ- rt 3 μ- Φ 0 CQ SD

3- l-h 3* tr 3 3 3 tr Hi d tn tr CQ Ω 3 TJ O SD H- Ω 3 3* 3 tr μ- Ω Ω ϋ rt IS,

0 Φ Φ SD rt P. SD ϋ tr1 Φ TJ rt d H- i 3 rt SD Φ CQ φ Ω SD rt φ CQ 0 l-h Hi CQ CQ d rt < 3^ CQ 3 ϋ . — . Φ ϋ 0 0 3 Φ 0 3 h-1 3 rt ii μ- H rt μ- LQ - Hi CQ

H- H- 3 d ^ ti tr Φ φ CQ 0 rf TJ CQ ^ Si SD ^ LQ μ- 0 Φ 0 ii μ- tr 3 tr φ CQ Ω H- φ TJ Z tr 3 Φ TJ < SD CQ Φ Φ CQ rt tr rt Φ rt tr 3 1 3 φ rt 0 LQ

TJ SD ^ 3* h 3 CQ SD tr ^ Φ Φ SD H- i 3 Ω Φ H- tr Φ Φ tr rt TJ Φ Z φ tr rt 3

0 φ H- CQ 0 0 LQ 0 tr H Φ rt H Pi Hi SD Ω SD SD 3 ii i TJ φ φ g tr 0 Φ tr SD

0 Si 3 d z SD M 3 0 H- 3 g ^ •x] SD Φ rt 3 φ 3 Hi o μ- Φ ti μ- Si CJ1 Φ Hi Hi Φ u PJ 0 t 3 CQ SD Φ S 3 Φ 0 H- H- 0 Ω Ω rt Φ SD ϋ Φ 3 SD 0 rt ti CO ti

3 LQ Φ 3* 3 3 Mi SD P. LQ h-1 CQ 3 z Φ 0 rt tr tr * ii M rt 3 tr rt o TJ z

C Ω Φ α rt Φ tr SD H- 3 d φ 0 φ ϋ 3" Φ H- ^ . d SD 0 Ω μ- Φ 3- 3 φ Ω μ- φ Φ 3 tr 3 TJ O Qi rt CQ tr CQ O ii 3 CQ O Φ Ml CQ ϋ Φ CQ ii Φ Ω 0

Ω H- SD Ω SD 13 3 tr ii Ml Φ φ 0 TJ rt 0 0 Ω rt ϋ H μ- Φ rt 3 rt μ- 3 u SD rt 3 r ti H Φ si. SD SD H- 0 rt Hi Φ tr rt H- M SD !-r H- 3 0 tr SD CQ 0 μ- t Hl CQ

Φ 3 - TJ O H- 3 rt 3 3 Ml 3 ι . O H- Φ Φ tr 3 CQ Φ Hi 3 SD Φ rt ii 3 Φ μ- μ- tr

SD u SD φ ΓT Si 3 SD rt 0 0 — 3 Ω u ϋ Φ TJ l-1 φ Hi tr μ- tr TJ Ω CQ φ

CD rt 3" tr 3 rt H- LQ 0 3 rt Mi 3 ii Φ Φ SD Φ o CQ ii Ω 3 φ CQ rt

Φ r SD Φ SD Φ u tr Ω Φ 3 μ- tr 0 SD rt rt Z Si SD SD 3 ii rt ; 0 μ- rt 0 TJ H Φ O - H- 3 i H 3 SD Φ O 3 rt Φ H 3 tr tr H- SD >r H- rt Φ tr CQ Φ 3 Hi ^ rt SD Φ Φ 3 φ

Φ CQ Ω Φ SD P. M tr SD h-1 0 3 LQ ϋ SD CQ 3 SD ϋ H- 3 rt CD Hi 3 Ω CQ Ω CQ

SD Φ ϋ rt SD Ω LQ ii H- ϋ SD φ o 3 Φ Ω LQ Ω rt Ω Φ ζ μ- φ σ CQ Ω μ- μ- <! CQ

CQ TJ H- SD φ tr d Φ 3 H- H- rt d Φ φ H- 0 • SD 3 0 CQ ϋ ^ 3 φ Hi CQ

H- M 0 CQ H- 0 3 SD P- Φ 3 3 H- H- LQ rt SD CQ SD CQ rt φ SD μ- rt LQ rt CQ Φ Hi Φ Mi TJ o 3 SD d LQ φ 0 3 tr tr 3 CQ H- LQ ≤ Φ 0 μ- Φ 3 3 CQ Ω SD CQ ii tr Ω CQ SD ti H- Φ H Ω rt Ω tr 3 SD α !-■• 3 TJ d tr CQ H CO 3 rt φ μ- 3 d Φ φ O Φ tr tr H H φ H- H- P- rt tr rt rt rt LQ ϋ Φ 3 Ω SD LQ ii Ω Ω SD

CQ 3 tr H- M SD 3* 0 3 0 3J Φ SD tr tr Ω 3 rt Φ SD 3 r 3 CQ Hi 3 TJ 3 Φ φ tr rt

<! μ- ft 0 H- 3 μ- rt SD 0 3 LQ 1 Φ rt tr φ Φ 0 0 SD tr CQ 3 tr μ- ϋ CQ SD SD CO

H- rt •> 0 CQ 3 H- LQ Hi H- z 0 Mi 3 Φ Φ rt rt Φ Ω ϋ 0 Φ ϋ μ- 0 SD P. O ; P- ? < o 0 H- rt SD 3 Ω φ d H- TJ CQ 3 tr ii d H) lP o rt CQ Hi CQ d

Ω D H- LQ 3 Ω rt 3J LQ T3 O φ rt 3 Φ tr H- TJ TJ rt s: Φ rt 0 Φ d Hi μ- Z rt ϋ

0 0 3 SD Ω rt Φ tr Φ Φ Φ SD 3 TJ i CQ ii Φ H- ϋ i 1 rt Φ Ω μ- SD Z μ- μ-

CQ l-h fi 3 0 H 3 ϋ Ω t f 3 Si LQ rt φ Hi 0 rt 0 i H- I-1 φ Φ Φ rt tr 3 rt 3 tr t- 3

H- u H. o 1 0 0 0 SD rt SD C rt tr Pi c 0 Φ ! Hi rt I-" SD 3 0 Φ Ω tr Φ I-" Ω μ- LQ rt rt rt H ϋ Φ 3 3 TJ CQ 3 tr Φ SD CQ Pi 3 H- C SD rt t CO μ- φ CQ φ Ω rt

^ 3J tr rt Φ tr Φ CQ TS tr ^ Ω SD Φ 3 H- Ω i CQ Z 3' ϋ 3 o Hi Φ φ rt 3* 3* TJ

Φ Φ t H- α -~ 0 SD φ rt Ω 0 ^ Φ μ- H- SD φ Φ 0 CQ Ω SD tr 0 Φ SD

SD ii Φ SD 0 d 3 H- rt ii H- 3 H- Φ 3 tr 0 h-1 < 3 μ- ii TJ - tr i φ Hi Si CQ

3 tr φ rt Ω 0 Ω μ- O Φ 3 0 Φ SD 0 H- 3 Φ H- rt CQ SD SD φ ii μ- Ω CQ

Pi Mi Ω H- H- H- rt SD Ω 0 Φ 3 SD 3 CQ rt rt Mi 3 3 3 μ- ϋ Z H φ tr Hi SD SD

0 0 o 0 3 3 et g d SD CQ φ H- d CQ CQ tr rt Pi 0 CQ 3 rt μ- SD TJ Hi Hi CQ LQ

Ω 0 H 3 3 TS LQ H- Ω TS CQ CQ P. d rt LQ tr Z TJ H- ^ Φ 0 H- Mi CQ μ- Ω SD 0 0 φ Φ Φ

0 u Φ Ω φ H- 0 0 SD Φ d d ii Φ 3 Φ tr 'SD LQ CQ Ω 0 rt Ω -> rt CQ ii 0 ti

3 • Φ Si Mi 3 3 i P. ii ϋ H- ii SD CQ Φ ii 3" rt σ SD rt Hi SD φ CQ Φ i CQ 0 0

Ω 3 SD Hi CQ TS SD φ H- 3 3 rt rt Φ φ rt 3- 3 Φ SD ϋ μ- Hi Hi

Φ Hi 1 3 Φ rt 3 LQ O H- H- 3 H- Φ Ω CQ I-1 μ- 3 3 rt

3 tr Ω H 0 H- H- LQ Mi CQ φ "* CQ CQ iQ 0 0 Φ Φ 3 0 1 rt

rt

0

Ω ϋ μ- rt

<!

SD

H d

Φ

According to the invention a relation can be formulated between the viscosity value, the electrical impedance, the haematocrit value, the. temperature and the sodium level in the blood. The latter three factors influence the impedance of the blood. A test arrangement with blood from ten volunteers was used to establish correlation coefficients for said relation. The test arrangement simulated a heart-lung machine. Gelofusine was also added to change the haematocrit value. It was found that:

(1) Ln (visco) = 0.774 + 2876 x 10"2 x HCT - 2.104 x 10"2 x T + 2.765 x 10"3 X Na.

(2) Ln (imp.) = 5.466 + 2.386 x 10"2 x HCT - 1.961 x 10"2 x T - 5.995 x 10"3 x Na. (3) Visco = 0.364 + 3.782 x 10"2 x imp., wherein Ln is the natural logarithm, visco is the viscosity value, HCT the haematocrit value, T the temperature, Na the sodium level, and imp. the impedance according to the measurement. Measurement took place in the test arrangement with an alternating current with a frequency of 20 kHz and an alternating current value of 300 μA.

During the test arrangement the levels of Ht, sodium, potassium, calcium and the pH were measured. Of these variables only the sodium was found to have significant influence on the impedance/viscosity. For the processing of the impedance measurement to a viscosity value a correction is therefore necessary which depends on the measured sodium concentration.

The third formula shows a direct correlation between the viscosity value and the impedance measurement.

In figure 5 is shown the correlation between the viscosity and the impedance of a test measurement with the blood of ten people. The viscosity and impedance are shown to be correlated. The measurement of the impedance can be used to determine the viscosity value. The processing means are provided with an algorithm which calculates the relation according to formula (3) , wherein a correction for the measured sodium concentration is also carried out .

Claims

1. Blood transporting machine, at least comprising transport means for transporting blood, wherein the blood transporting machine is further provided with a device for electrical impedance measurement of the blood, which comprises means for generating an electrical current in the blood, means for measuring the electrical impedance and means for recording the electrical impedance and/or impedance change in the blood, characterized in that the blood transporting machine also comprises processing means for processing recorded impedance to a blood viscosity value.
2. Blood transporting machine as claimed in claim 1, characterized in that the machine is provided with means for functioning as heart-lung machine.
3. Blood transporting machine as claimed in claim 1, characterized in that transport means comprise at least one perfusion tube and the current generating means and the measuring means are arranged in the perfusion tube close to the source thereof out of the blood transporting machine.
4. Blood transporting machine as claimed in claim 1, 2 or 3 , characterized in that the current generating means comprise a set of current generating electrodes which are connected to a source of alternating voltage and which can generate an alternating current in the blood.
5. Blood transporting machine as claimed in any of the claims 1-4, characterized in that the measuring means comprise a set of measuring electrodes.
6. Blood transporting machine as claimed in claim 4 or 5, characterized in that the electrodes are circular.
7. Blood transporting machine as claimed in claim 4, 5 or 6, characterized in that the electrodes are platinum .electrodes .
8. Blood transporting machine as claimed in any of the foregoing claims 1-7, characterized in that the electrodes are arranged at a regular distance from each other in the perfusion tube in the direction of the blood flow.
9. Blood transporting machine as claimed in claim 8, characterized in that the distance is at least twice the diameter of the perfusion tube.
10. Blood transporting machine as claimed in any of the foregoing claims, characterized in that in the direction of the blood flow the current generating electrodes comprise the outer electrodes and the measuring electrodes the inner electrodes .
11. Blood transporting machine as claimed in any of the foregoing claims, characterized in that means are also arranged for measuring the sodium concentration in the blood.
12. Blood transporting machine as claimed in claim 11, characterized in that the processing means can cor- rect the blood viscosity value for the measured sodium concentration .
13. Blood transporting machine as claimed in any of the foregoing claims, characterized in that means are also arranged for measuring the haematocrit value of the blood.
14. Blood transporting machine as claimed in any of the foregoing claims, characterized in that the processing means determine the viscosity value with an algorithm for the impedance measurement, wherein the algo- rithm depends on the temperature and the haematocrit value .
15. Blood transporting machine as claimed in any of the foregoing claims, characterized in that the algorithm comprises correction coefficients for the dependence of the viscosity value on temperature and haematocrit value during an impedance measurement .
16. Use of a blood transporting machine as claimed in any of the foregoing claims for detecting the occurrence of embolisms in the blood.
17. Use as claimed in claim 13, characterized in that the embolisms comprise air embolisms and/or micro- embolisms .
PCT/NL2001/000701 2000-09-22 2001-09-24 Heart-lung machine provided with a device for electrical impedance measurement, and method therefore WO2002025277A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NL1016247 2000-09-22
NL1016247A NL1016247C2 (en) 2000-09-22 2000-09-22 Heart-lung machine provided with a device for electrical impedance measurement for the detection of microemboliÙn and / or fibrinogen concentration.

Publications (1)

Publication Number Publication Date
WO2002025277A1 true true WO2002025277A1 (en) 2002-03-28

Family

ID=19772129

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NL2001/000701 WO2002025277A1 (en) 2000-09-22 2001-09-24 Heart-lung machine provided with a device for electrical impedance measurement, and method therefore

Country Status (2)

Country Link
NL (1) NL1016247C2 (en)
WO (1) WO2002025277A1 (en)

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005059532A1 (en) * 2003-12-16 2005-06-30 Dynabyte Informationssysteme Gmbh Cartridge device for blood analysis
EP2187201A1 (en) * 2003-12-16 2010-05-19 Dynabyte Informationssysteme GmbH Cartridge device for blood analysis
US20100153029A1 (en) * 2007-01-08 2010-06-17 Vibro-Meter, Inc. System and method for optimizing sweep delay and aliasing for time domain reflectometric measurement of liquid height within a tank
WO2011144511A1 (en) * 2010-05-11 2011-11-24 Fresenius Medical Care Deutschland Gmbh Method and apparatus for determining cellular and/or extracellular, in particular macromolecular, portions of fluids, preferably bodily fluids, of living beings
US8388546B2 (en) 2006-10-23 2013-03-05 Bard Access Systems, Inc. Method of locating the tip of a central venous catheter
US8388541B2 (en) 2007-11-26 2013-03-05 C. R. Bard, Inc. Integrated system for intravascular placement of a catheter
US8393208B2 (en) 2007-10-01 2013-03-12 Meggitt (New Hampshire), Inc. Measuring of fluid in a vessel with two coaxial cable sections and a coupling therebetween using time domain reflectometry
US8437833B2 (en) 2008-10-07 2013-05-07 Bard Access Systems, Inc. Percutaneous magnetic gastrostomy
US8478382B2 (en) 2008-02-11 2013-07-02 C. R. Bard, Inc. Systems and methods for positioning a catheter
US8512256B2 (en) 2006-10-23 2013-08-20 Bard Access Systems, Inc. Method of locating the tip of a central venous catheter
US8549909B2 (en) 2007-10-01 2013-10-08 Meggitt (Orange County), Inc. Vessel probe connector with solid dielectric therein
USD699359S1 (en) 2011-08-09 2014-02-11 C. R. Bard, Inc. Ultrasound probe head
US8781555B2 (en) 2007-11-26 2014-07-15 C. R. Bard, Inc. System for placement of a catheter including a signal-generating stylet
US8784336B2 (en) 2005-08-24 2014-07-22 C. R. Bard, Inc. Stylet apparatuses and methods of manufacture
US8801693B2 (en) 2010-10-29 2014-08-12 C. R. Bard, Inc. Bioimpedance-assisted placement of a medical device
US8849382B2 (en) 2007-11-26 2014-09-30 C. R. Bard, Inc. Apparatus and display methods relating to intravascular placement of a catheter
WO2014162285A1 (en) * 2013-04-03 2014-10-09 Universita' Degli Studi Di Udine Apparatus for analyzing the process of formation of aggregates in a biological fluid and corresponding method of analysis
US9125578B2 (en) 2009-06-12 2015-09-08 Bard Access Systems, Inc. Apparatus and method for catheter navigation and tip location
US9211107B2 (en) 2011-11-07 2015-12-15 C. R. Bard, Inc. Ruggedized ultrasound hydrogel insert
US9339206B2 (en) 2009-06-12 2016-05-17 Bard Access Systems, Inc. Adaptor for endovascular electrocardiography
US9445734B2 (en) 2009-06-12 2016-09-20 Bard Access Systems, Inc. Devices and methods for endovascular electrography
WO2016152304A1 (en) * 2015-03-20 2016-09-29 ソニー株式会社 Blood state monitoring device, method for monitoring blood state, blood state monitoring system, and blood state improving program
US9456766B2 (en) 2007-11-26 2016-10-04 C. R. Bard, Inc. Apparatus for use with needle insertion guidance system
US9492097B2 (en) 2007-11-26 2016-11-15 C. R. Bard, Inc. Needle length determination and calibration for insertion guidance system
US9521961B2 (en) 2007-11-26 2016-12-20 C. R. Bard, Inc. Systems and methods for guiding a medical instrument
US9532724B2 (en) 2009-06-12 2017-01-03 Bard Access Systems, Inc. Apparatus and method for catheter navigation using endovascular energy mapping
US9554716B2 (en) 2007-11-26 2017-01-31 C. R. Bard, Inc. Insertion guidance system for needles and medical components
US9636031B2 (en) 2007-11-26 2017-05-02 C.R. Bard, Inc. Stylets for use with apparatus for intravascular placement of a catheter
US9649048B2 (en) 2007-11-26 2017-05-16 C. R. Bard, Inc. Systems and methods for breaching a sterile field for intravascular placement of a catheter
US9839372B2 (en) 2014-02-06 2017-12-12 C. R. Bard, Inc. Systems and methods for guidance and placement of an intravascular device
US9901714B2 (en) 2008-08-22 2018-02-27 C. R. Bard, Inc. Catheter assembly including ECG sensor and magnetic assemblies

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4014206A (en) 1975-03-31 1977-03-29 Akron City Hospital Apparatus and method for monitoring air emboli during extracorporeal circulation
US4835477A (en) * 1986-08-16 1989-05-30 Fresenius Ag Process for the determination of the hematocrit level of whole blood and apparatus for carrying out the process
EP0542140A2 (en) * 1991-11-15 1993-05-19 Fresenius AG Tube arrangement for use in a blood circuit
WO2000074775A1 (en) * 1999-06-03 2000-12-14 Martil Instruments B.V. Method, device and catheter for in vivo determining blood properties such as blood viscosity

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4014206A (en) 1975-03-31 1977-03-29 Akron City Hospital Apparatus and method for monitoring air emboli during extracorporeal circulation
US4835477A (en) * 1986-08-16 1989-05-30 Fresenius Ag Process for the determination of the hematocrit level of whole blood and apparatus for carrying out the process
EP0542140A2 (en) * 1991-11-15 1993-05-19 Fresenius AG Tube arrangement for use in a blood circuit
WO2000074775A1 (en) * 1999-06-03 2000-12-14 Martil Instruments B.V. Method, device and catheter for in vivo determining blood properties such as blood viscosity

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
VRIES DE P M J M ET AL: "IMPLICATIONS OF THE DIELECTRICAL BEHAVIOUR OF HUMAN BLOOD FOR CONTINUOUS ONLINE MEASUREMENT OF HAEMATOCRIT", MEDICAL AND BIOLOGICAL ENGINEERING AND COMPUTING,GB,PETER PEREGRINUS LTD. STEVENAGE, vol. 31, no. 5, 1 September 1993 (1993-09-01), pages 445 - 448, XP000400532, ISSN: 0140-0118 *

Cited By (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005059532A1 (en) * 2003-12-16 2005-06-30 Dynabyte Informationssysteme Gmbh Cartridge device for blood analysis
EP2187201A1 (en) * 2003-12-16 2010-05-19 Dynabyte Informationssysteme GmbH Cartridge device for blood analysis
US8465978B2 (en) 2003-12-16 2013-06-18 F. Hoffmann-La Roche Ag Method for conducting platelete aggregation analysis by a cartridge device
US7901629B2 (en) 2003-12-16 2011-03-08 Dynabyte Informationssysteme Gmbh Cartridge device for blood analysis
US8877510B2 (en) 2003-12-16 2014-11-04 F. Hoffmann-La Roche Ag Method for conducting platelet aggregation analysis
US8591816B2 (en) 2003-12-16 2013-11-26 F. Hoffmann-La Roche Ag Cartridge device for blood analysis
US10004875B2 (en) 2005-08-24 2018-06-26 C. R. Bard, Inc. Stylet apparatuses and methods of manufacture
US8784336B2 (en) 2005-08-24 2014-07-22 C. R. Bard, Inc. Stylet apparatuses and methods of manufacture
US8388546B2 (en) 2006-10-23 2013-03-05 Bard Access Systems, Inc. Method of locating the tip of a central venous catheter
US9265443B2 (en) 2006-10-23 2016-02-23 Bard Access Systems, Inc. Method of locating the tip of a central venous catheter
US9345422B2 (en) 2006-10-23 2016-05-24 Bard Acess Systems, Inc. Method of locating the tip of a central venous catheter
US8512256B2 (en) 2006-10-23 2013-08-20 Bard Access Systems, Inc. Method of locating the tip of a central venous catheter
US8774907B2 (en) 2006-10-23 2014-07-08 Bard Access Systems, Inc. Method of locating the tip of a central venous catheter
US8858455B2 (en) 2006-10-23 2014-10-14 Bard Access Systems, Inc. Method of locating the tip of a central venous catheter
US9833169B2 (en) 2006-10-23 2017-12-05 Bard Access Systems, Inc. Method of locating the tip of a central venous catheter
US20100153029A1 (en) * 2007-01-08 2010-06-17 Vibro-Meter, Inc. System and method for optimizing sweep delay and aliasing for time domain reflectometric measurement of liquid height within a tank
US8794063B2 (en) 2007-01-08 2014-08-05 Meggitt (Orange County), Inc. System and method for optimizing sweep delay and aliasing for time domain reflectometric measurement of liquid height within a tank
US9453755B2 (en) 2007-10-01 2016-09-27 Meggitt (Orange County), Inc. TDR fluid level sensor
US8393208B2 (en) 2007-10-01 2013-03-12 Meggitt (New Hampshire), Inc. Measuring of fluid in a vessel with two coaxial cable sections and a coupling therebetween using time domain reflectometry
US8549909B2 (en) 2007-10-01 2013-10-08 Meggitt (Orange County), Inc. Vessel probe connector with solid dielectric therein
US9549685B2 (en) 2007-11-26 2017-01-24 C. R. Bard, Inc. Apparatus and display methods relating to intravascular placement of a catheter
US9456766B2 (en) 2007-11-26 2016-10-04 C. R. Bard, Inc. Apparatus for use with needle insertion guidance system
US8781555B2 (en) 2007-11-26 2014-07-15 C. R. Bard, Inc. System for placement of a catheter including a signal-generating stylet
US9492097B2 (en) 2007-11-26 2016-11-15 C. R. Bard, Inc. Needle length determination and calibration for insertion guidance system
US9636031B2 (en) 2007-11-26 2017-05-02 C.R. Bard, Inc. Stylets for use with apparatus for intravascular placement of a catheter
US8388541B2 (en) 2007-11-26 2013-03-05 C. R. Bard, Inc. Integrated system for intravascular placement of a catheter
US9521961B2 (en) 2007-11-26 2016-12-20 C. R. Bard, Inc. Systems and methods for guiding a medical instrument
US9526440B2 (en) 2007-11-26 2016-12-27 C.R. Bard, Inc. System for placement of a catheter including a signal-generating stylet
US9999371B2 (en) 2007-11-26 2018-06-19 C. R. Bard, Inc. Integrated system for intravascular placement of a catheter
US9649048B2 (en) 2007-11-26 2017-05-16 C. R. Bard, Inc. Systems and methods for breaching a sterile field for intravascular placement of a catheter
US8849382B2 (en) 2007-11-26 2014-09-30 C. R. Bard, Inc. Apparatus and display methods relating to intravascular placement of a catheter
US9681823B2 (en) 2007-11-26 2017-06-20 C. R. Bard, Inc. Integrated system for intravascular placement of a catheter
US9554716B2 (en) 2007-11-26 2017-01-31 C. R. Bard, Inc. Insertion guidance system for needles and medical components
US8971994B2 (en) 2008-02-11 2015-03-03 C. R. Bard, Inc. Systems and methods for positioning a catheter
US8478382B2 (en) 2008-02-11 2013-07-02 C. R. Bard, Inc. Systems and methods for positioning a catheter
US9901714B2 (en) 2008-08-22 2018-02-27 C. R. Bard, Inc. Catheter assembly including ECG sensor and magnetic assemblies
US9907513B2 (en) 2008-10-07 2018-03-06 Bard Access Systems, Inc. Percutaneous magnetic gastrostomy
US8437833B2 (en) 2008-10-07 2013-05-07 Bard Access Systems, Inc. Percutaneous magnetic gastrostomy
US9125578B2 (en) 2009-06-12 2015-09-08 Bard Access Systems, Inc. Apparatus and method for catheter navigation and tip location
US9339206B2 (en) 2009-06-12 2016-05-17 Bard Access Systems, Inc. Adaptor for endovascular electrocardiography
US9445734B2 (en) 2009-06-12 2016-09-20 Bard Access Systems, Inc. Devices and methods for endovascular electrography
US9532724B2 (en) 2009-06-12 2017-01-03 Bard Access Systems, Inc. Apparatus and method for catheter navigation using endovascular energy mapping
WO2011144511A1 (en) * 2010-05-11 2011-11-24 Fresenius Medical Care Deutschland Gmbh Method and apparatus for determining cellular and/or extracellular, in particular macromolecular, portions of fluids, preferably bodily fluids, of living beings
US9823207B2 (en) 2010-05-11 2017-11-21 Fresenius Medical Care Deutschland Gmbh Method and device for determining intracellular and/or extracellular, in particular macromolecular fractions of fluids, preferably of body fluids of living organisms
US8801693B2 (en) 2010-10-29 2014-08-12 C. R. Bard, Inc. Bioimpedance-assisted placement of a medical device
US9415188B2 (en) 2010-10-29 2016-08-16 C. R. Bard, Inc. Bioimpedance-assisted placement of a medical device
USD699359S1 (en) 2011-08-09 2014-02-11 C. R. Bard, Inc. Ultrasound probe head
USD754357S1 (en) 2011-08-09 2016-04-19 C. R. Bard, Inc. Ultrasound probe head
US9211107B2 (en) 2011-11-07 2015-12-15 C. R. Bard, Inc. Ruggedized ultrasound hydrogel insert
WO2014162285A1 (en) * 2013-04-03 2014-10-09 Universita' Degli Studi Di Udine Apparatus for analyzing the process of formation of aggregates in a biological fluid and corresponding method of analysis
US9839372B2 (en) 2014-02-06 2017-12-12 C. R. Bard, Inc. Systems and methods for guidance and placement of an intravascular device
WO2016152304A1 (en) * 2015-03-20 2016-09-29 ソニー株式会社 Blood state monitoring device, method for monitoring blood state, blood state monitoring system, and blood state improving program

Also Published As

Publication number Publication date Type
NL1016247C2 (en) 2002-03-25 grant

Similar Documents

Publication Publication Date Title
US3459176A (en) Apparatus and method of sampling a dialyzable component of blood
US5456253A (en) Disposable extracorporeal conduit for blood constituent monitoring
US6514225B1 (en) Dialysis pressure monitoring with clot suppression
US5024756A (en) Dialysis system and method therefor
US5505828A (en) Calibration solutions useful for analysis of biological fluids and methods employing same
Depner et al. Clinical measurement of blood flow in hemodialysis access fistulae and grafts by ultrasound dilution.
US20070088333A1 (en) Method and system for infusing an osmotic solute into a patient and providing feedback control of the infusing rate
US6599277B2 (en) Aspiration flow meter and control
US4209392A (en) Portable hepatic-assist method and apparatus for same
EP2005982A1 (en) Method for determining the reduction ratio or the Kt/V value of a kidney substitution treatment and apparatus for the realisation of the method
US5220920A (en) Electrochemical measurement system having interference reduction circuit
Nässberger et al. Exposure of patients to phthalates from polyvinyl chloride tubes and bags during dialysis
US4791932A (en) Extracorporeal sensing module
EP0417796A2 (en) Hematocrit measuring instrument
US20040254513A1 (en) Conductive polymer materials and applications thereof including monitoring and providing effective therapy
US7410473B2 (en) Blood pump having a disposable blood filter with integrated pressure sensors
US20080065006A1 (en) Enhanced signal detection for access disconnection systems
WO2008028653A2 (en) Device and method for monitoring an access to a patient, in particular a vascular access in extracorporeal blood treatment
WO2011053810A2 (en) Apparatus and method for detecting disconnection of an intravascular access device
Sternberg et al. Subcutaneous glucose concentration in humans: real estimation and continuous monitoring
US6663585B1 (en) Method and device for monitoring vessel access during extracorporeal blood treatment
US5644240A (en) Differential conductivity hemodynamic monitor
US20020174721A1 (en) Method and device for detecting stenoses in a tubular line system
Travagli et al. A physicochemical investigation on the effects of ozone on blood
US20070179433A1 (en) Pressure sensing

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2001982926

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001982926

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP